From a spot of cancer in her lung, it has metastasised to her bladder and now she has inoperable lesions on her brain. She said: “The consultant came to see me and said a possible option was to ...

Overactive bladder (OAB) is a group of symptoms that are not usually life-threatening but can significantly decrease productivity and quality of life. The condition is characterized by the sudden need ...

Michael Menna, DO, is currently an attending emergency medicine physician at White Plains Hospital in White Plains, New York, with nearly 10 years of experience. Rich Scherr is an updates ...

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for bladder cancer in 2021, failed its confirmatory trial earlier this year. Gilead ...

The setback in bladder cancer is a small disappointment, representing less than 10% of sales compared with 90% in breast cancer, TD Securities analyst Tyler Van Buren wrote in a note to clients. Van ...